FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns a biologically active additive mix exhibiting neuroprotective activity which contains a peptide composition containing two peptides with sequence 1: NMVPFPR and sequence 2: ASAFQGIGSTHWVYDGVGNS.
EFFECT: invention provides improved neuroprotective action; prevention, relief or barrier of neurodegeneration; prevention, barrier and/or relief of cognitive function reduction.
14 cl, 7 ex, 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| DONECOPRID AS A NEUROPROTECTIVE AGENT IN THE TREATMENT OF NEURODEGERATIVE DISEASES | 2019 |
|
RU2800802C2 |
| NEW APPLICATION | 2004 |
|
RU2416426C2 |
| NOVEL NUTRACEUTICAL COMPOSITIONS CONTAINING STEVIA EXTRACT OR STEVIA EXTRACT COMPONENTS AND USES THEREOF | 2008 |
|
RU2519718C2 |
| METHOD FOR CORRECTING NEUROLOGICAL DISTURBANCES ACCOMPANYING ALCOHOL INTOXICATION | 2014 |
|
RU2561063C1 |
| METHOD FOR CORRECTING POSTISCHEMIC COGNITIVE DYSFUNCTION | 2006 |
|
RU2315618C1 |
| LACTOFERRIN AND DEVELOPMENT OF HEALTHY BRAIN IN BABIES | 2010 |
|
RU2568596C2 |
| DERIVATIVES OF 5B-SAPOGENIN AND PSEUDO SAPOGENIN AND APPLICATION FOR DEMENTIA MEDICAL TREATMENT | 2000 |
|
RU2325396C2 |
| METHOD FOR MAKING NEUROTRANSPLANTATION USING PLURIPOTENT NEUROEPITHELIAL CELLS | 1996 |
|
RU2185833C2 |
| LACTOFERRIN AND HEALTHY BRAIN DEVELOPING IN INFANTS | 2010 |
|
RU2688671C2 |
| COMBINATION FOR TREATING AND PREVENTING BEHAVIOURAL, MENTAL, COGNITIVE AND NEUROLOGICAL DISORDERS ACCOMPANYING ORGANIC CNS DISEASES | 2012 |
|
RU2493838C1 |
